Medical News

RSS
Viewpoints on debt-ceiling debate center on Medicare

Viewpoints on debt-ceiling debate center on Medicare

Intuity Medical closes second tranche of Series D Preferred Stock financing

Intuity Medical closes second tranche of Series D Preferred Stock financing

Femta files IND with FDA for FM101 monoclonal antibody against RA

Femta files IND with FDA for FM101 monoclonal antibody against RA

Disparities persist despite insurance

Disparities persist despite insurance

Prohibitive costs prevent elders from sticking to prescribed medication

Prohibitive costs prevent elders from sticking to prescribed medication

Health Robotics report record-breaking results for second-quarter 2011

Health Robotics report record-breaking results for second-quarter 2011

HT, B.Braun partner to launch Adenocaine Hiberplegia syringe pump delivery system

HT, B.Braun partner to launch Adenocaine Hiberplegia syringe pump delivery system

Bipartisan support for NIH funding eroding

Bipartisan support for NIH funding eroding

Auxilium second quarter net loss decreases to $5.1 million

Auxilium second quarter net loss decreases to $5.1 million

Medical device review system called into question

Medical device review system called into question

FDA approves Covidien's morphine sulfate oral solution for chronic pain in opioid-tolerant patients

FDA approves Covidien's morphine sulfate oral solution for chronic pain in opioid-tolerant patients

FDA approves Medtronic's IDE for Advisa DR MRI SureScan pacing system

FDA approves Medtronic's IDE for Advisa DR MRI SureScan pacing system

First Edition: August 1, 2011

First Edition: August 1, 2011

Vanda, Biotoscana Farma partner to commercialize Fanapt in Argentina

Vanda, Biotoscana Farma partner to commercialize Fanapt in Argentina

Mobile health software effectively helps manage diabetes

Mobile health software effectively helps manage diabetes

Widespread, institutional corruption in American science, scientist says

Widespread, institutional corruption in American science, scientist says

CBIZ enters definitive agreement to acquire Multiple Benefit Services

CBIZ enters definitive agreement to acquire Multiple Benefit Services

Positive results from Alnylam's ALN-VSP Phase I trial for liver cancer

Positive results from Alnylam's ALN-VSP Phase I trial for liver cancer

Merck submits ridaforolimus MAA with EMA for treatment of metastatic soft-tissue, bone sarcomas

Merck submits ridaforolimus MAA with EMA for treatment of metastatic soft-tissue, bone sarcomas

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.